A detailed history of Choreo, LLC transactions in Danaher Corp stock. As of the latest transaction made, Choreo, LLC holds 20,792 shares of DHR stock, worth $4.78 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
20,792
Previous 19,608 6.04%
Holding current value
$4.78 Million
Previous $4.9 Million 17.96%
% of portfolio
0.08%
Previous 0.08%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$239.25 - $280.76 $283,272 - $332,419
1,184 Added 6.04%
20,792 $5.78 Million
Q2 2024

Aug 06, 2024

BUY
$235.51 - $267.98 $3.94 Million - $4.49 Million
16,743 Added 584.4%
19,608 $4.9 Million
Q1 2024

May 02, 2024

SELL
$224.58 - $256.19 $94,099 - $107,343
-419 Reduced 12.76%
2,865 $715,000
Q4 2023

Feb 05, 2024

BUY
$185.1 - $233.13 $386,673 - $487,008
2,089 Added 174.81%
3,284 $759,000
Q3 2023

Nov 08, 2023

BUY
$233.08 - $265.59 $41,721 - $47,540
179 Added 17.62%
1,195 $296,000
Q2 2023

Aug 04, 2023

SELL
$224.99 - $256.14 $39,148 - $44,568
-174 Reduced 14.62%
1,016 $243,000
Q1 2023

May 15, 2023

BUY
$239.75 - $277.0 $285,302 - $329,630
1,190 New
1,190 $299,000
Q1 2022

May 02, 2022

SELL
$257.27 - $315.76 $195,782 - $240,293
-761 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$292.08 - $329.01 $222,272 - $250,376
761 New
761 $250,000
Q3 2021

Nov 08, 2021

SELL
$272.21 - $332.43 $249,072 - $304,173
-915 Closed
0 $0
Q1 2021

Apr 29, 2021

SELL
$212.38 - $245.9 $58,829 - $68,114
-277 Reduced 23.24%
915 $206,000
Q4 2020

Feb 04, 2021

BUY
$212.5 - $245.46 $18,275 - $21,109
86 Added 7.78%
1,192 $265,000
Q3 2020

Nov 03, 2020

SELL
$177.16 - $215.33 $32,774 - $39,836
-185 Reduced 14.33%
1,106 $238,000
Q2 2020

Aug 14, 2020

BUY
$128.7 - $176.83 $166,151 - $228,287
1,291 New
1,291 $228,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $167B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Choreo, LLC Portfolio

Follow Choreo, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Choreo, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Choreo, LLC with notifications on news.